Patient undergoing general anesthesia and i-gel insertion
Conditions
Interventions
Remimazolam and sevoflurane are administered at assigned doses during general anesthesia.
Sponsors
Kobayashi Kensuke
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients who are between 40 and 60 years of age at the time of consent 2. patients scheduled for i-gel insertion for non-emergency (scheduled or temporary) surgery 3. patients with ASA (American Society of Anesthesiologists) Class I or II status 4. patients who have given their consent to this study by signing the consent form
Exclusion criteria
Exclusion criteria: 1. those who are expected to have difficulty in intubation (e.g., with impaired opening, Mallampati Grade III or IV, etc.) 2. 2. patients undergoing surgery requiring intubation 3. patients with symptoms of airway infection 4. benzodiazepines or benzodiazepines 4. patients with a history of hypersensitivity to benzodiazepines or flumazenil 5. patients who should avoid sevoflurane (e.g., history of malignant hyperthermia or family history of malignant hyperthermia) 6. patients with a history of hypersensitivity to rocuronium 7. severely obese (BMI > 35) Pregnant patients 9. nursing mothers and postpartum mothers 10. patients with the possibility of aspiration 11.Patients with a history of hypersensitivity to remimazolam 12.Patients with a history of glaucoma 13.Patients who regularly use benzodiazepines 14.Persons with psychiatric disorders 15. other patients who are judged to be exempted by the principal investigator/associate investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bispectral index (with a cutoff value of 60) | — |
Secondary
| Measure | Time frame |
|---|---|
| Bispectral index (50 and 70 as cutoff values, respectively) | — |
Contacts
Public ContactKensuke Kobayashi
Hamamatsu University Hospital
Outcome results
None listed